Jacqueline C. Barrientos

Hematology
410 Lakeville Rd Ste 212
New Hyde Park, NY 11042

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 107 publications

Deep Learning-Based Detection Model for Leukemia Cells in Peripheral Blood Smears Using YOLOv11-Large.

Deep Learning-Based Detection Model for Leukemia Cells in Peripheral Blood Smears Using YOLOv11-Large.

Journal: Current oncology (Toronto, Ont.)
Published: June 26, 2026

Clinicopathologic features of lymphoma-associated hemophagocytic lymphohistiocytosis in a multicenter adult cohort.

Clinicopathologic features of lymphoma-associated hemophagocytic lymphohistiocytosis in a multicenter adult cohort.

Journal: Leukemia & lymphoma
Published: April 29, 2026

Chronic Lymphocytic Leukemia: Molecular Pathologies and Therapeutic Strategies.

Chronic Lymphocytic Leukemia: Molecular Pathologies and Therapeutic Strategies.

Journal: International journal of molecular sciences
Published: April 10, 2026

Real-World Data of R-mini-CHOP Therapy in Elderly Hispanic Population with Diffuse Large B-Cell Lymphoma and High-Grade Follicular Lymphoma.

Real-World Data of R-mini-CHOP Therapy in Elderly Hispanic Population with Diffuse Large B-Cell Lymphoma and High-Grade Follicular Lymphoma.

Journal: Cancers
Published: March 06, 2026

Updated consensus guidelines for the diagnosis and management of patients with HCL and HCL variant.

Updated consensus guidelines for the diagnosis and management of patients with HCL and HCL variant.

Journal: Blood
Published: January 05, 2026

Updated consensus guidelines for the diagnosis and management of patients with hairy cell leukemia (HCL) and HCL-variant.

Updated consensus guidelines for the diagnosis and management of patients with hairy cell leukemia (HCL) and HCL-variant.

Journal: Blood
Published: January 05, 2026

Final phase 2 study results of acalabrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemia.

Final phase 2 study results of acalabrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemia.

Journal: Blood advances
Published: September 25, 2025

Final phase 2 study results of acalabrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemia.

Final phase 2 study results of acalabrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemia.

Journal: Blood advances
Published: September 25, 2025

Clinical strategies for lymphoma management: Recommendations from the Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Consensus Conference 2025.

Clinical strategies for lymphoma management: Recommendations from the Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Consensus Conference 2025.

Journal: Cancer
Published: September 24, 2025

Hemophagocytic Lymphohistiocytosis as First Manifestation of Dual B-Cell Neoplasms: A Case Report of Co-Existing Multiple Myeloma and B-Cell Lymphoma.

Hemophagocytic Lymphohistiocytosis as First Manifestation of Dual B-Cell Neoplasms: A Case Report of Co-Existing Multiple Myeloma and B-Cell Lymphoma.

Journal: EJHaem
Published: May 20, 2025

Refractory immune thrombocytopenic purpura (ITP) secondary to prior COVID-19 infection requiring a splenectomy.

Refractory immune thrombocytopenic purpura (ITP) secondary to prior COVID-19 infection requiring a splenectomy.

Journal: BMJ case reports
Published: November 24, 2024

Perspectives on Current Challenges and Emerging Approaches for Lymphoma Management From the First Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Conference.

Perspectives on Current Challenges and Emerging Approaches for Lymphoma Management From the First Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Conference.

Journal: Clinical lymphoma, myeloma & leukemia
Published: November 21, 2024
Showing 1-12 of 107

Last Updated: 09/26/2026